Reaction

Shoulder Operation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,160 reports · 96 co-occurring drugs

As of the last recalculation, Shoulder Operation appears in 4,160 FAERS reports alongside 96 co-occurring drug terms. The strongest observed disproportionality signal is CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES (PRR 27.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Calcium, Magnesium, Potassium, And Sodium Oxybates	46	27.0	27.2
Upadacitinib	307	20.3	20.3
Risankizumab-Rzaa	272	17.7	17.8
Sodium Oxybate	162	12.8	12.8
Oxycodone And Acetaminophen Tablets	16	6.7	6.7
Armodafinil	28	6.7	6.7
Eptinezumab-Jjmr	12	6.6	6.6
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	43	6.1	6.2
Modafinil	39	6.1	6.1
Oxymorphone Hydrochloride	13	5.6	5.6
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate	45	5.5	5.5
Fexofenadine Hcl	10	5.4	5.4
Naltrexone Hydrochloride And Bupropion Hydrochloride	9	5.3	5.3
Tofacitinib	166	4.6	4.7
Pancrelipase	35	4.6	4.6
Meloxicam	52	4.5	4.5
Methocarbamol Tablets	15	4.5	4.5
Cyclobenzaprine Hydrochloride	8	4.5	4.5
Hyoscyamine Sulfate	8	4.4	4.4
Esketamine Hydrochloride	15	4.2	4.2
Methocarbamol	19	4.2	4.2
Oxycodone And Acetaminophen	19	4.1	4.1
Tizanidine	19	4.0	4.0
Linaclotide	21	4.0	4.0
Cyclobenzaprine	39	3.9	3.9
Ranolazine	8	3.8	3.8
Cetirizine Hcl	7	3.8	3.8
Belimumab	24	3.8	3.8
Vilazodone Hydrochloride	7	3.8	3.8
Lubiprostone	7	3.7	3.7
Hydroxychloroquine Sulfate	65	3.6	3.6
Icosapent Ethyl	6	3.5	3.5
Ibrutinib	56	3.5	3.5
Rizatriptan Benzoate	7	3.4	3.4
Adalimumab	449	3.4	3.4
Sulfasalazine	53	3.4	3.4
Thyroid, Porcine	7	3.3	3.3
Acetaminophen And Codeine	8	3.3	3.3
Cariprazine	6	3.2	3.2
Certolizumab Pegol	74	3.2	3.2
Golimumab	54	3.2	3.2
Methylphenidate Hydrochloride	37	3.1	3.1
Etanercept	349	3.1	3.1
Azelastine	11	3.1	3.1
Sitagliptin And Metformin Hydrochloride	13	3.0	3.0
Oral Semaglutide	44	3.0	3.0
Finasteride	36	3.0	3.0
Vortioxetine	10	2.9	2.9
Cenegermin-Bkbj	7	2.9	2.9
Sarilumab	15	2.8	2.8
Bimekizumab	12	2.8	2.8
Abatacept	77	2.8	2.8
Oxycodone Hydrochloride And Acetaminophen	55	2.8	2.8
Tolvaptan	8	2.8	2.8
Levocetirizine Dihydrochloride	13	2.7	2.7
Agalsidase Beta	5	2.7	2.7
Fluticasone Propionate And Salmeterol	22	2.6	2.6
Bosentan	26	2.6	2.6
Teriflunomide	23	2.6	2.6
Relugolix	12	2.6	2.6
Vibegron	4	2.5	2.5
Etonogestrel And Ethinyl Estradiol	11	2.5	2.5
Ixekizumab	18	2.4	2.4
Naltrexone	15	2.4	2.4
Hydrocodone Bitartrate And Acetaminophen	27	2.4	2.4
Mometasone Furoate And Formoterol Fumarate Dihydrate	7	2.2	2.2
Brivaracetam	4	2.2	2.2
Tafamidis	5	2.1	2.1
Carbidopa And Levodopa	20	2.1	2.1
Methylphenidate	12	2.1	2.1
Asfotase Alfa	4	2.0	2.0
Diclofenac Potassium	4	1.9	1.9
Glatiramer Acetate	22	1.8	1.8
Romosozumab-Aqqg	5	1.8	1.8
Teriparatide	39	1.7	1.7
Ustekinumab	35	1.7	1.7
Dupilumab	162	1.7	1.7
Rucaparib	3	1.7	1.7
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	14	1.7	1.7
Guselkumab	12	1.7	1.7
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	3	1.7	1.7
Rimegepant Sulfate	4	1.6	1.6
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	3	1.5	1.5
Ambrisentan	37	1.5	1.5
Patiromer	4	1.4	1.4
Onabotulinumtoxina	22	1.4	1.4
Apremilast	41	1.4	1.4
Glecaprevir And Pibrentasvir	3	1.4	1.4
Erenumab-Aooe	15	1.4	1.4
Evolocumab	43	1.3	1.3
Emtricitabine And Tenofovir Alafenamide	3	1.3	1.3
Alirocumab	6	1.2	1.2
Varenicline Tartrate	18	1.1	1.1
Pimavanserin Tartrate	11	1.0	1.0
Droxidopa	4	0.9	0.9
Valbenazine	4	0.8	0.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.